6 recent drug company acquisitions

Since Nov. 1, the following drugmakers have announced or completed acquisitions:

Note: This is not an exhaustive list. Deals were reported by Becker's Hospital Review and are presented in the order in which they were reported.

  1. Astellas Pharma to acquire Audentes Therapeutics in $3B deal
    Astellas Pharma, a Tokyo, Japan-based drugmaker, plans to acquire San Francisco-based Audentes Therapeutics for about $3 billion.

  2. Novartis pays $9.7B to acquire Medicines Co.
    Novartis has acquired Parsipanny, N.J.-based drugmaker Medicines Co. for $9.7 billion.

  3. Alkermes to acquire Rodin Therapeutics
    Alkermes will acquire Boston-based drugmaker Rodin Therapeutics for $100 million to expand its portfolio of drugs to treat neurodegenerative disorders.

  4. FTC clears Bristol-Myers takeover of Celgene
    The Federal Trade Commission cleared the way for Bristol-Myers Squibb to complete its acquisition of Celgene for $74 billion, one of the largest deals in pharmaceutical history.

  5. Roche to buy small Massachusetts drugmaker for $390M
    Roche will pay $390 million to purchase a small Lexington, Mass.-based drugmaker, Promedior.

  6. Amgen invests $2.7B in Chinese drugmaker
    Amgen is investing $2.7 billion in a Chinese drugmaker, BeiGene, giving it a 20.5 percent stake in the company.

More articles on pharmacy:
Top 5 pharmacy stories in November
Juno Therapeutics co-founder starting new drug company
Parents in Europe crowdsource $2.7M to buy world's most expensive drug for their toddler

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars